Comparative efficacy and safety of picankibart versus guselkumab and tildrakizumab for moderate-to-severe plaque psoriasis: a systematic review and individual participant data-anchored population-adjusted network meta-analysis

AME Medical Journal · Published 2026-06-01 · DOI 10.21037/amj-2026-0041

Free full text

Authors (6)

Mengxia Yan, Ying Chen, Wen Li, Yun Bao, Kaijie Yao, Bin Wu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Yan, M., Chen, Y., Li, W., et al. (2026). Comparative efficacy and safety of picankibart versus guselkumab and tildrakizumab for moderate-to-severe plaque psoriasis: a systematic review and individual participant data-anchored population-adjusted network meta-analysis. AME Medical Journal. https://doi.org/10.21037/amj-2026-0041

Related articles